Title: Prediction of human population responses to toxic compounds by a collaborative competition.
Authors: Eduati, Federica; Mangravite, Lara M; Wang, Tao; Tang, Hao; Bare, J Christopher; Huang, Ruili; Norman, Thea; Kellen, Mike; Menden, Michael P; Yang, Jichen; Zhan, Xiaowei; Zhong, Rui; Xiao, Guanghua; Xia, Menghang; Abdo, Nour; Kosyk, Oksana; NIEHS-NCATS-UNC DREAM Toxicogenetics Collaboration; Friend, Stephen; Dearry, Allen; Simeonov, Anton; Tice, Raymond R; Rusyn, Ivan; Wright, Fred A; Stolovitzky, Gustavo; Xie, Yang; Saez-Rodriguez, Julio
Published In Nat Biotechnol, (2015 Sep)
Abstract: The ability to computationally predict the effects of toxic compounds on humans could help address the deficiencies of current chemical safety testing. Here, we report the results from a community-based DREAM challenge to predict toxicities of environmental compounds with potential adverse health effects for human populations. We measured the cytotoxicity of 156 compounds in 884 lymphoblastoid cell lines for which genotype and transcriptional data are available as part of the Tox21 1000 Genomes Project. The challenge participants developed algorithms to predict interindividual variability of toxic response from genomic profiles and population-level cytotoxicity data from structural attributes of the compounds. 179 submitted predictions were evaluated against an experimental data set to which participants were blinded. Individual cytotoxicity predictions were better than random, with modest correlations (Pearson's r < 0.28), consistent with complex trait genomic prediction. In contrast, predictions of population-level response to different compounds were higher (r < 0.66). The results highlight the possibility of predicting health risks associated with unknown compounds, although risk estimation accuracy remains suboptimal.
PubMed ID: 26258538
MeSH Terms: Computer Simulation; Dose-Response Relationship, Drug; Genetic Predisposition to Disease/genetics*; Genetics, Population; Hazardous Substances/toxicity*; High-Throughput Screening Assays/methods*; Humans; Incidence; Lymphocytes/cytology; Lymphocytes/drug effects*; Lymphocytes/physiology; Models, Genetic*; Risk Assessment/methods; Toxicity Tests/methods